|
US2016113936A1
|
|
Methods for modulating monocyte function
|
|
US2015297310A1
|
|
Methods for selecting a treatment for cancer
|
|
US2015056194A1
|
|
Modified green tea polyphenols and methods thereof for treating liver disease
|
|
WO2015027071A1
|
|
Gpr81 agonists and methods thereof for promoting production of secretory iga
|
|
US2015025052A1
|
|
Compositions and Methods for Inhibiting HSP90/HSP70 Machinery
|
|
US2014288010A1
|
|
Compositions and Methods for Increasing Stem Cell Survival
|
|
US2014171504A1
|
|
Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
|
|
US2014105869A1
|
|
Compositions and methods for treating musculoskeletal diseases and disorders
|
|
US2014100262A1
|
|
Methods and Compositions for Maintaining Blood-Brain Barrier Integrity
|
|
US2013115170A1
|
|
GM1-like peptides and uses thereof
|
|
EP2467495A2
|
|
Diagnosing and managing venous thromboembolism and intracardiac thrombi using a provoked d-dimer test
|
